Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
Physiology guided heart procedures show lower risk of major events
Physiology-guided revascularization significantly reduces major adverse cardiac events and improves safety profiles compared to traditional …
A large international trial shows that using functional imaging to guide heart artery procedures may lower the risk of stroke and heart atta…
Ticagrelor monotherapy following primary PCI for STEMI shows reduced non-access site bleeding
Trial shows ticagrelor monotherapy may reduce bleeding after heart attack
This pilot study compared ticagrelor monotherapy against ticagrelor plus aspirin in patients with STEMI after primary PCI. The trial reporte…
A pilot study suggests that using ticagrelor alone after a heart attack may reduce specific types of bleeding compared to a dual-drug approa…
High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
High dose statins may improve outcomes for heart attack patients
This meta-analysis of 1862 patients with STEMI undergoing primary PCI indicates that high-dose statin preloading is associated with improved…
A high dose of statins before a heart procedure may improve blood flow and lower death rates for patients with a heart attack.
Pressure optimization protocol improves reperfusion success and reduces postdilation in STEMI patients
New stenting technique improves blood flow after heart attacks
This multicenter randomized trial of 607 patients undergoing primary PCI for STEMI found that a pressure optimization protocol (POP) signifi…
A new pressure optimization method during heart surgery helps restore blood flow faster and reduces the need for extra procedures.
Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI
Intracoronary Thrombolysis Linked to Lower Risks After Heart Attack
This meta-analysis evaluated the impact of adjunctive intracoronary thrombolysis during primary percutaneous coronary intervention for patie…
Adding intracoronary thrombolysis during heart procedures may lower the risk of major complications and improve blood flow for patients with…
Persistent microvascular obstruction predicts higher MACE and death risks following ST-segment elevation myocardial infarction
Persistent heart muscle damage after heart attack increases risk
This meta-analysis of 2180 patients with STEMI identifies persistent microvascular obstruction as a significant prognostic indicator. Persis…
Patients with lasting microvascular obstruction after a heart attack face higher risks of death and major complications compared to those wi…
Intracoronary mesenchymal stem cell administration improves left ventricular ejection fraction following ST-segment elevation myocardial infarction
Stem cells improve heart function after heart attack but not outcomes
This meta-analysis of 8 randomized controlled trials found that intracoronary mesenchymal stem cell (MSC) administration significantly impro…
New data shows stem cell treatment improves heart muscle pumping power after a heart attack, though it does not yet reduce hospital visits o…
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
Ticagrelor Shows Lower Mortality Risk Than Clopidogrel for Heart Patients
This meta-analysis of 31,729 adult STEMI patients post-PCI found that ticagrelor significantly reduced all-cause mortality (OR = 0.64) and m…
A large analysis of over 31,000 patients suggests ticagrelor may lower mortality and heart attack risks compared to clopidogrel after a hear…
Transvalvular microaxial flow pump plus PCI does not reduce infarct size in anterior STEMI
Trial shows microaxial flow pump does not reduce heart damage
This randomized controlled trial of 527 adults with acute anterior STEMI found that LV unloading with a transvalvular microaxial flow pump f…
A clinical trial found that using a transvalvular microaxial flow pump before heart surgery did not reduce the size of heart tissue damage.
Staged revascularization shows no significant difference versus immediate revascularization for major adverse cardiovascular events in STEMI and MVD patients
Timing of heart surgery does not change survival for a specific heart attack group
This meta-analysis reviewed 5077 patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease comparing …
A large review found that waiting for staged heart surgery did not improve survival or reduce heart attacks compared to immediate surgery fo…
Prehospital unfractionated heparin bolus improved TIMI flow in STEMI without increasing bleeding risk
Pretreatment with UFH improves artery flow for STEMI patients without extra bleeding risk
This single-center randomized trial evaluated pretreatment with unfractionated heparin in patients with ST-segment-elevation myocardial infa…
Giving unfractionated heparin early at first medical contact improved artery flow in heart attack patients without increasing bleeding risk.
Intracoronary nicorandil improves TIMI flow and reduces AMR in STEMI patients undergoing primary PCI
New Drug Opens Tiny Vessels After Heart Attack Treatment
This single-center randomized trial enrolled 63 patients with first-episode ST-segment elevation myocardial infarction undergoing primary PC…
A new drug given during heart surgery may help blood flow reach the heart muscle better.
Research across Myocardial ischemia
Related studies from across the Myocardial ischemia family.
High-intensity statin adherence correlates with greater LDL-C reductions and improved plaque stability post-AMI
High-Intensity Statins Show Better Results for Heart Patients Following Heart Attack
This randomized controlled trial sub-study of 255 patients with acute myocardial infarction evaluated high-intensity statin therapy. Adheren…
Patients who strictly followed their high-intensity statin regimen after a heart attack showed significantly better improvements in heart he…
GLP-1 receptor agonists reduce MACE (HR 0.69) and all-cause mortality (HR 0.67) in Type 2 Diabetes
GLP-1 medications show promise for heart health in diabetes
This meta-analysis of 37,393 patients with Type 2 Diabetes and myocardial infarction-defined populations found that GLP-1 receptor agonists …
A large review of over 37,000 patients suggests GLP-1 medications may lower heart failure risks for those with Type 2 Diabetes.
Ticagrelor monotherapy after primary PCI shows 3.1% MACCE versus 2.0% in DAPT group
Trial shows ticagrelor alone may reduce bleeding after heart attack
This pilot randomized controlled trial of 200 STEMI patients compared ticagrelor monotherapy to ticagrelor plus aspirin (DAPT) after primary…
A new trial looks at whether using one blood thinner instead of two can reduce bleeding risks for patients after a heart attack.
Moderate-intensity aerobic exercise improves cardiopulmonary function and pathological remodeling in myocardial infarction patients
Different types of exercise help heart health after a heart attack
This network meta-analysis of 3170 patients with myocardial infarction (MI) evaluated various exercise modalities for improving cardiopulmon…
New data shows that different types of exercise, from aerobic training to mind-body movements, can improve heart function after a heart atta…
R.E.N.A.L., PADUA, and (MC)2 scoring systems correlate with increased complication risks in renal tumor ablation
Scoring systems help predict complications after renal tumor ablation
This meta-analysis of 25 retrospective studies evaluates the R.E.N.A.L., PADUA, and (MC)2 scoring systems for predicting complications follo…
New analysis shows that specific scoring systems can help doctors predict and manage risks for patients undergoing surgery to remove kidney …
Eight traditional Chinese medicine injections combined with conventional medicine improve outcomes in post-AMI heart failure
Comparing Different Traditional Chinese Medicine Injections for Heart Failure Recovery
This systematic review and network meta-analysis of 62 RCTs involving 5922 participants evaluated eight traditional Chinese medicine injecti…
New research looks at how different herbal injections can help patients recover from heart attacks when used with standard medicine.
Traditional Chinese medicine integrated with cardiac rehabilitation addresses inflammation, autonomic dysfunction, and psychological disorders
Traditional Chinese medicine may help patients recover from heart attacks
This narrative review examines the integration of Traditional Chinese medicine (TCM) into cardiac rehabilitation for patients with cardiovas…
Integrating Traditional Chinese medicine with standard cardiac rehab could help manage inflammation and stress after heart surgery or a hear…
Dual antiplatelet therapy reduces all-cause death but not MACE or myocardial infarction in MINOCA
Dual antiplatelet therapy shows survival benefits for MINOCA patients
This meta-analysis of 13027 patients with myocardial infarction with nonobstructive coronary artery disease (MINOCA) found that dual antipla…
New data suggests that dual antiplatelet therapy may help reduce the risk of death in patients with a specific type of heart attack.
Beta-blocker therapy shows variable outcomes for myocardial infarction patients based on ejection fraction
Beta-blockers show mixed results for patients with heart conditions
This meta-analysis examined the impact of oral beta-blockers on composite outcomes including death and heart failure in patients following m…
New data shows that beta-blocker medication helps some people after a heart attack, but it may not help everyone equally.
Inflammatory bowel disease is associated with increased risk of MACE and all-cause mortality
Inflammatory bowel disease linked to higher heart attack risks
This systematic review and meta-analysis of 9 retrospective cohort studies involving 9.45 million patients found that inflammatory bowel dis…
People with inflammatory bowel disease face a significantly higher risk of heart complications and death following a heart attack.
SGLT2 inhibitors and GLP-1 receptor agonists show similar MACE reduction in type 2 diabetes
Trial shows similar heart benefits for two diabetes medications
This systematic review and network meta-analysis compared SGLT2 inhibitors and GLP-1 receptor agonists for major adverse cardiovascular even…
Two common types of diabetes drugs both show significant reductions in major heart events for patients with a history of heart attacks.
Behavioral and metabolic factors characterize a distinct premature atherosclerosis phenotype in Chinese patients
Smoking and Metabolic Factors Linked to Heart Attacks in China
This systematic review of 317 observational studies maps risk factors for premature myocardial infarction (PMI) in China. The synthesis iden…
A large review of 317 studies identifies specific behavioral and metabolic risk factors for heart attacks among Chinese patients.
Questions about ST-Segment Elevation Myocardial Infarction
Are many current STEMI treatment guidelines based on strong scientific evidence?
No, many current STEMI treatment guidelines are based on moderate or low-quality evidence, with only a small fraction supported by high-level studies.
Full answer →Can a CT scan show hidden lung water that predicts bad outcomes in STEMI?
Yes, a CT scan can detect hidden lung water (extravascular lung water) in STEMI patients, and this finding is linked to a higher risk of in-hospital major adverse cardiovascular events.
Full answer →How accurate is the new model for predicting heart failure after STEMI surgery?
A new model predicts acute heart failure after STEMI PCI with 82.4% accuracy, 74% sensitivity, and 86.8% specificity, outperforming older scores.
Full answer →Does the timing of my heart surgery affect how well blood flows in STEMI?
Yes, timing matters: longer delays from symptom onset to PCI are linked to worse blood flow and outcomes in STEMI.
Full answer →Can taking nicorandil during heart surgery improve blood flow for STEMI patients?
Yes, a 2024 trial found that giving intracoronary nicorandil during primary PCI improves blood flow (TIMI grade) and reduces microvascular resistance in STEMI patients.
Full answer →All ST-Segment Elevation Myocardial Infarction Articles
- Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
- Ticagrelor monotherapy following primary PCI for STEMI shows reduced non-access site bleeding
- High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
- Pressure optimization protocol improves reperfusion success and reduces postdilation in STEMI patients
- Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI
- Persistent microvascular obstruction predicts higher MACE and death risks following ST-segment elevation myocardial infarction
- Intracoronary mesenchymal stem cell administration improves left ventricular ejection fraction following ST-segment elevation myocardial infarction
- Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
- Transvalvular microaxial flow pump plus PCI does not reduce infarct size in anterior STEMI
- Staged revascularization shows no significant difference versus immediate revascularization for major adverse cardiovascular events in STEMI and MVD patients
- Prehospital unfractionated heparin bolus improved TIMI flow in STEMI without increasing bleeding risk
- Intracoronary nicorandil improves TIMI flow and reduces AMR in STEMI patients undergoing primary PCI
- Atorvastatin dose and PCI timing predict hypoperfusion in STEMI patients
- Predictive model for acute heart failure in STEMI patients after PCI shows high accuracy
- Residual global μQFR assessment associated with 3-year MACE risk in acute coronary syndrome patients
- CT-detected subclinical pulmonary congestion associated with in-hospital MACE in Killip class 1 STEMI
- STEMI guidelines rely heavily on moderate and low-quality evidence, meta-analysis finds
- Retrospective study identifies five predictors for hypokalemia in STEMI patients
- Phase 2 trial tests pre-hospital glucocorticoid pulse in STEMI patients undergoing primary PCI
- Immediate revascularization tied to higher 1-year risk in STEMI with multivessel disease and heart failure